Cite
HARVARD Citation
Arai, Y. et al. (2017). Increased non‐relapse mortality due to high‐dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults. British journal of haematology. pp. 106-111. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arai, Y. et al. (2017). Increased non‐relapse mortality due to high‐dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults. British journal of haematology. pp. 106-111. [Online].